IGF2 and juvenile Huntington disease: In addition, genetic targeting of XBP1 in the mouse brain was recently shown to trigger protective compesatory events resulting in the upregulation of IGF2, improving proteostasis in models of Huntington's disease (García‐Huerta et al., 2020).